Your browser doesn't support javascript.
loading
MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway.
Aersilan, Alimasi; Hashimoto, Naoko; Yamagata, Kazuyuki; Yokoyama, Masataka; Nakayama, Akitoshi; Shi, Xiaoyan; Nagano, Hidekazu; Sakuma, Ikki; Nohata, Nijiro; Kinoshita, Takashi; Seki, Naohiko; Rahmutulla, Bahityar; Kaneda, Atsushi; Zhahara, Siti Nurul; Gong, Yingbo; Nishimura, Motoi; Kawauchi, Shoichiro; Kawakami, Eiryo; Tanaka, Tomoaki.
Afiliação
  • Aersilan A; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Hashimoto N; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Yamagata K; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Yokoyama M; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Nakayama A; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Shi X; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Nagano H; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Sakuma I; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Nohata N; Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kinoshita T; MSD K.K., Tokyo, Japan.
  • Seki N; Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Rahmutulla B; Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kaneda A; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Zhahara SN; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Gong Y; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Nishimura M; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
  • Kawauchi S; Division of Laboratory Medicine, Clinical Genetics and Proteomics, Chiba University Hospital, Chiba, Japan.
  • Kawakami E; Advanced Data Science Project (ADSP), RIKEN, Kanagawa, Japan.
  • Tanaka T; Advanced Data Science Project (ADSP), RIKEN, Kanagawa, Japan.
Sci Rep ; 12(1): 18443, 2022 11 02.
Article em En | MEDLINE | ID: mdl-36323841
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article